🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Testing procedure for Binding antibodies

Found 13 matching trials

Evaluation of a Novel Diagnostic Kit for the Detection of Placental Alpha-Microglobulin-1 in the Prediction of Preterm Birth

N/A

This is a prospective observational trial that will enroll pregnant women b...

Status

Completed

Location

Prof. Dr. Daniel Surbek

Start Date

2013-12

Trial ID

NCT02092688

Treatments Being Tested

novel kit for the detection of PAMG-1

Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)

PHASE1

Tegoprubart (AT-1501) is a monoclonal antibody. Antibodies are Y-shaped pro...

Status

Active Not Recruiting

Location

University of Chicago

Start Date

2024-03-04

Trial ID

NCT06305286

Treatments Being Tested

Islet transplantation with Tegoprubart (AT-1501) immunosupression-based therapy

Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

PHASE2

This phase II trial compares cabozantinib alone and the combination of cabo...

Status

Active Not Recruiting

Location

Veterans Administration Medical Center - Birmingham

Start Date

2020-07-13

Trial ID

NCT04310007

Treatments Being Tested

Biospecimen Collection Cabozantinib S-malate Computed Tomography Docetaxel Echocardiography Test Gemcitabine Hydrochloride Nab-paclitaxel Nivolumab Paclitaxel Ramucirumab

Rapid Diagnosis of Heparin-Induced Thrombocytopenia in Surgical Critically Ill Patients

N/A

The early diagnosis of heparin-induced thrombocytopenia is particularly dif...

Status

Completed

Location

Centre Hospitalier Universitaire de Besançon

Start Date

2012-10

Trial ID

NCT02790567

Treatments Being Tested

HEP score 4Ts score ID-PaGIA test HIT-Ab(PF4-H) test

Antibodies Responses to COVID-19 Infection in Hospitalized Patients

N/A

1.5. Why this clinical study? The prevalence of seropositivity following S...

Status

Unknown

Location

Imam Abdulrahman Bin Faisal University

Start Date

2020-08

Trial ID

NCT04520880

Treatments Being Tested

Testing procedure for Binding antibodies Neutralizing antibodies

Lingual Nerve Disruption to Augment Neoadjuvant Chemoimmunotherapy in Locally Advanced Tongue Cancer

PHASE2

The goal of this clinical trial is to evaluate the feasibility and prelimin...

Status

Not Yet Recruiting

Location

Zhongshan Hospital Fudan University

Start Date

2026-01-01

Trial ID

NCT07346807

Treatments Being Tested

Lingual Nerve Disruption Tislelizumab Albumin-bound Paclitaxel Cisplatin Peripheral Blood Collection for Immune Monitoring Pain and Quality of Life Assessment

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

PHASE3

This phase III trial compares the effect of adding stereotactic body radiat...

Status

Recruiting

Location

University of Alabama at Birmingham Cancer Center

Start Date

2023-07-12

Trial ID

NCT05624996

Treatments Being Tested

Carboplatin Cisplatin Computed Tomography Durvalumab Etoposide Image Guided Radiation Therapy Nab-paclitaxel Osimertinib Paclitaxel Pemetrexed Positron Emission Tomography Questionnaire Administration Stereotactic Body Radiation Therapy

Effect of Point-of-care Analysis of Ultrasensitive Troponin I on Length of Hospital Stay in Patients With Cardiac Chest Pain (POC Troponina)

This clinical study aims to compare two different methods for measuring hig...

Status

Recruiting

Location

Instituto do Coração HCFMUSP

Start Date

2025-03-10

Trial ID

NCT06861582

Treatments Being Tested

Point-of-care ultrasensitive troponin testing Laboratory-based ultrasensitive troponin testing

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

PHASE2

This phase II MYELOMATCH treatment trial compares the effect of venetoclax ...

Status

Recruiting

Location

Memorial Hospital West

Start Date

2027-02-02

Trial ID

NCT06917911

Treatments Being Tested

Biospecimen Collection Bone Marrow Aspiration Cytarabine Daunorubicin Hydrochloride Echocardiography Test Gemtuzumab Ozogamicin Multigated Acquisition Scan Venetoclax

Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer

The goal of this clinical study is to evaluate the potential benefits of in...

Status

Recruiting

Location

University Hospital Ulm Gynecology/Obstetrics

Start Date

2022-12-07

Trial ID

NCT05658172

Treatments Being Tested

Determination of tumormarkers (CA27.29, CEA, CA125)Determination of CTC levels Determination of ctDNA levels Biobanking of blood samples

Previous Next